SuMarket

Spero Therapeutics, Inc. SPRO

$1.20 -0.83% · NasdaqGS

Filings
  1. Aug 288-KDeals & acquisitionsentered a material agreementSEC ↗
  2. Aug 128-Kreported quarterly resultsSEC ↗
  3. Aug 1210-Qfiled its quarterly reportSEC ↗
  4. Jul 148-KDeals & acquisitionsentered a material agreementSEC ↗
  5. Jun 258-KExecutive changesannounced an executive or director changeSEC ↗
  6. Jun 228-Kissued a regulatory disclosureSEC ↗
  7. May 1310-Qfiled its quarterly reportSEC ↗
  8. May 138-Kreported quarterly resultsSEC ↗
  9. Mar 268-Kreported quarterly resultsSEC ↗
  10. Mar 2610-Kfiled its annual reportSEC ↗
  11. Jan 308-KExecutive changesannounced an executive or director changeSEC ↗
  12. Dec 198-Kdisclosed another material eventSEC ↗

SPRO’s dossier

A standing writeup of what the company does and how it is trading, kept current, with a dated note on every earnings, filing and unexplained move.

Dossiers are part of Pro. Price and filings above are free.

Reported financials

Revenue, margin and the balance sheet as the company reported them to the SEC.

Free · no card